Publications by authors named "Ross D Merkin"

Claim this Profile
S
Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma.
Daniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, Ross D Merkin, Evelyn Luciani

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs)" [Best Pract Res Clin Haematol 38 2 2025].
Matthew J Hadfield, Ross D Merkin, Sherin J Rouhani, Kerry L Reynolds

Best Pract Res Clin Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer.
Daniel A Ruiz-Torres, Ross D Merkin, Michael E Bryan, Julia Mendel, Vasileios Efthymiou

NPJ Precis Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Long-Term Survival in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
Nikhil Dubey, Chia-Yun Wu, Leyre Zubiri, Magdalena Fay, Sherin J Rouhani, Ross D Merkin

J Am Heart Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs).
Matthew J Hadfield, Ross D Merkin, Sherin J Rouhani, Kerry L Reynolds

Best Pract Res Clin Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible downregulation of HLA class I in adenoid cystic carcinoma.
Annie Li, Bianca L Gonda, Elizabeth M Codd, Adam von Paternos, Dawn R Mitchell, Ross D Merkin

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer.
Daniel A Ruiz-Torres, Ross D Merkin, Michael Bryan, Julia Mendel, Vasileios Efthymiou

medRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck Cancer.
Daniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, Ross D Merkin, Evelyn Luciani

medRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis.
Jacqueline E Mann, Liliana Lucca, Matthew R Austin, Ross D Merkin, Marie E Robert

J Immunother Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
David A Schoenfeld, Myrto Moutafi, Sandra Martinez, Dijana Djureinovic, Ross D Merkin

J Immunother Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy?
Ross D Merkin, Veronica L Chiang, Sarah B Goldberg

Ther Adv Med Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance.
David A Schoenfeld, Ross D Merkin, Myrto Moutafi, Sandra Martinez, Adebowale Adeniran

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
Ross D Merkin, Elizabeth A Vanner, Jamie L Romeiser, A Laurie W Shroyer, Luisa F Escobar-Hoyos

Hum Pathol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
Shawn M Hillier, Kevin P Maresca, Genliang Lu, Ross D Merkin, John C Marquis

J Nucl Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis